[go: up one dir, main page]

PE20081403A1 - Nebulizador anticonceptivo oral - Google Patents

Nebulizador anticonceptivo oral

Info

Publication number
PE20081403A1
PE20081403A1 PE2007001765A PE2007001765A PE20081403A1 PE 20081403 A1 PE20081403 A1 PE 20081403A1 PE 2007001765 A PE2007001765 A PE 2007001765A PE 2007001765 A PE2007001765 A PE 2007001765A PE 20081403 A1 PE20081403 A1 PE 20081403A1
Authority
PE
Peru
Prior art keywords
nebulizer
formulation
oral contraceptive
contraceptive
etonogestrel
Prior art date
Application number
PE2007001765A
Other languages
English (en)
Inventor
Kees Van Der Voort Maarschalk
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of PE20081403A1 publication Critical patent/PE20081403A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

REFERIDA A UNA FORMULACION ANTICONCEPTIVA LIQUIDA QUE COMPRENDE ETONOGESTREL Y OPCIONALMENTE ETINILESTRADIOL, DONDE DICHA FORMULACION NO COMPRENDE UN FORMADOR DE MATRIZ O UN PROMOTOR DE ABSORCION PERCUTANEO TAL COMO UN ACIDO HIDROXI. LA FORMULACION SE ADMINISTRA VIA MUCOSA ORAL A MANERA DE NEBULIZACION
PE2007001765A 2006-12-12 2007-12-11 Nebulizador anticonceptivo oral PE20081403A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06125961 2006-12-12

Publications (1)

Publication Number Publication Date
PE20081403A1 true PE20081403A1 (es) 2008-10-04

Family

ID=38521609

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001765A PE20081403A1 (es) 2006-12-12 2007-12-11 Nebulizador anticonceptivo oral

Country Status (10)

Country Link
US (1) US20100105641A1 (es)
EP (1) EP2120874A2 (es)
AR (1) AR064602A1 (es)
CA (1) CA2671469A1 (es)
CL (1) CL2007003592A1 (es)
MX (1) MX2009006316A (es)
PE (1) PE20081403A1 (es)
SG (1) SG144065A1 (es)
TW (1) TW200840595A (es)
WO (1) WO2008071429A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ATE288255T1 (de) * 1996-04-12 2005-02-15 Novadel Pharma Inc Polares bukkales spray
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
US6506742B2 (en) * 1999-12-13 2003-01-14 Ortho-Mcneil Pharmaceutical, Inc. Soluble contraceptive liquid formulation
WO2003068315A1 (en) * 2002-02-15 2003-08-21 Pantarhei Bioscience B.V. A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males
AU2003296810A1 (en) * 2002-12-10 2004-07-09 Besins International Belgique Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof

Also Published As

Publication number Publication date
EP2120874A2 (en) 2009-11-25
WO2008071429A3 (en) 2008-10-09
WO2008071429A2 (en) 2008-06-19
MX2009006316A (es) 2009-06-23
SG144065A1 (en) 2008-07-29
AR064602A1 (es) 2009-04-15
US20100105641A1 (en) 2010-04-29
CA2671469A1 (en) 2008-06-19
TW200840595A (en) 2008-10-16
CL2007003592A1 (es) 2008-06-20

Similar Documents

Publication Publication Date Title
NZ597354A (en) Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
WO2007134292A3 (en) Treprostinil administration using a metered dose inhaler
GT200900175A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
NZ587561A (en) Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist)
MY160074A (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
NZ589928A (en) Inhaler
NZ548225A (en) Inhalant formulation containing sulfoakyl ether cyclodextrin and corticosteroid
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
BRPI0607574A2 (pt) composição farmacêutica aerossol
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
BR112012013847A2 (pt) novos derivados de indolinona ciclopropano
EA201001285A1 (ru) Применение 25-oh d3 для воздействия на физиологию мышц человека
BR0313526A (pt) Medicamento inalativos que contêm um agente anticolinérigo, em combinação com corticoesteróides e betamiméticos
CL2011002100A1 (es) Composicion farmaceutica que comprende (4ar,10ar)-1-n-propil-1,2,3,4,4a,5,10,10a-octahidro-benzo[g]quinolin-6,7-diol y sus derivados, para administracion por mucosa oral, nasal o a traves de la piel; y su uso para el tratamiento de la enfermedad de parkinson.
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
PE20121467A1 (es) Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
PE20011223A1 (es) Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico
EP2380569A3 (de) Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
ATE491441T1 (de) Antivirale zusammensetzung mit p-menthan-3,8-diol
PE20081403A1 (es) Nebulizador anticonceptivo oral
CL2008001282A1 (es) Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria.
MX2007006775A (es) Composiciones estables de fenofibrato con esteres de acido graso.
UY28096A1 (es) Nueva formulación pulveurlenta que contiene tiotropio destinada a la inhalación

Legal Events

Date Code Title Description
FD Application declared void or lapsed